Relative Importance of Heart Failure Events Compared to Stroke and Bleeding in AF Patients
- PMID: 33670912
- PMCID: PMC7957734
- DOI: 10.3390/jcm10050923
Relative Importance of Heart Failure Events Compared to Stroke and Bleeding in AF Patients
Abstract
Introduction: Incident heart failure (HF), ischemic stroke and systemic embolism (IS/SE), and major bleeding related to anticoagulation therapy are still the most frequent events occurring in patients with atrial fibrillation (AF). The aim of this study was to assess the 3-year incidence, predictors, and related mortality of IS/SE, major bleeding, and HF in a large cohort of AF outpatients.
Methods and results: We studied 4973 outpatients with prevalent AF included in the CARDIONOR registry. The mean age was 72.9 ± 11.2 years, 24.1% had diabetes mellitus and 78.9% had anticoagulant therapy at baseline. The mean CHA2DS2Vasc score was 3.4 ± 1.7. After a median follow-up of 3.2 years (IQR: 2.8 to 3.5), incident HF, IS/SE and major bleeding occurred in 10.5%, 3.3% and 2.1% of patients, respectively. When analyzed as time-dependent variables, IS/SE, major bleeding and hospitalization for decompensated HF were all strongly associated with mortality. The independent predictors of incident HF were age, women, hypertension, diabetes mellitus, coronary artery disease and a previous history of HF. A sensitivity analysis in patients without history of HF at inclusion revealed that incident HF remained the most frequent adverse event, occurring in 5.3% of patients, compared to IS/SE (1.7%) and major bleeding (2.5%).
Conclusion: HF is a common residual cardiovascular adverse event occurring in AF outpatients and is associated with a very high mortality. Since modifiable risk factors are associated with incident HF, upstream intensive management of these risk factors would be of interest.
Keywords: atrial fibrillation; bleeding; heart failure; stroke.
Conflict of interest statement
Lemesle reports personal fees from Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, MSD, Mylan, Novartis, Pfizer, Sanofi-Aventis, and Servier. Lamblin reports personal fees from Actelion, Akcea, Amicus therapeutics, Bayer, Novartis, MSD, Pfizer, and Sanofi-Aventis and travel grants from Amgen and Bristol-Myers Squibb. Ninni, Meurice, Tricot, and Bauters had nothing to disclose.
Figures


Similar articles
-
Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.Eur J Heart Fail. 2013 Apr;15(4):415-24. doi: 10.1093/eurjhf/hft004. Epub 2013 Jan 9. Eur J Heart Fail. 2013. PMID: 23302606
-
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.JACC Heart Fail. 2017 Jan;5(1):44-52. doi: 10.1016/j.jchf.2016.09.016. JACC Heart Fail. 2017. PMID: 28034376
-
Real-Life Incident Atrial Fibrillation in Outpatients with Coronary Artery Disease.J Clin Med. 2020 Jul 24;9(8):2367. doi: 10.3390/jcm9082367. J Clin Med. 2020. PMID: 32722139 Free PMC article.
-
Anticoagulation Therapy and NOACs in Heart Failure.Handb Exp Pharmacol. 2017;243:515-535. doi: 10.1007/164_2016_126. Handb Exp Pharmacol. 2017. PMID: 28233177 Review.
-
Unraveling the Paradox: Can Anticoagulation Improve Outcomes in Patients With Heart Failure and Increased Bleeding Risk?Cureus. 2024 Apr 3;16(4):e57544. doi: 10.7759/cureus.57544. eCollection 2024 Apr. Cureus. 2024. PMID: 38707016 Free PMC article. Review.
Cited by
-
Factors influencing self-control in older patients with atrial fibrillation following radiofrequency catheter ablation: a cross-sectional study based on triadic reciprocal determinism.BMC Geriatr. 2025 Jul 5;25(1):499. doi: 10.1186/s12877-025-06141-y. BMC Geriatr. 2025. PMID: 40618013 Free PMC article.
-
Determinants of Prolonged Length of Hospital Stay of Patients with Atrial Fibrillation.J Clin Med. 2021 Aug 20;10(16):3715. doi: 10.3390/jcm10163715. J Clin Med. 2021. PMID: 34442009 Free PMC article.
-
Relationship of diabetes, heart failure, and N-terminal pro-B-type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation.ESC Heart Fail. 2022 Aug;9(4):2367-2377. doi: 10.1002/ehf2.13930. Epub 2022 May 20. ESC Heart Fail. 2022. PMID: 35593128 Free PMC article.
-
Atrial Fibrillation Ablation: Impact on Burden and Cardiovascular Outcomes.J Clin Med. 2025 Apr 12;14(8):2648. doi: 10.3390/jcm14082648. J Clin Med. 2025. PMID: 40283478 Free PMC article. Review.
-
Machine Learning Risk Prediction for Incident Heart Failure in Patients With Atrial Fibrillation.JACC Asia. 2022 Nov 1;2(6):706-716. doi: 10.1016/j.jacasi.2022.07.007. eCollection 2022 Nov. JACC Asia. 2022. PMID: 36444329 Free PMC article.
References
-
- Magnussen C., Niiranen T.J., Ojeda F.M., Gianfagna F., Blankenberg S., Njølstad I., Vartiainen E., Sans S., Pasterkamp G., Hughes M., et al. Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe) Circulation. 2017;136:1588–1597. doi: 10.1161/CIRCULATIONAHA.117.028981. - DOI - PMC - PubMed
-
- Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomström-Lundqvist C., Boriani G., Castella M., Dan G.-A., Dilaveris P.E., et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 2021;42:373–498. - PubMed
-
- Virani Salim S., Alonso A., Aparicio Hugo J., Benjamin Emelia J., Bittencourt Marcio S., Callaway C.W., Carson A.P., Chamberlain A.M., Cheng S., Delling F.N., et al. Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association. Circulation. 2021 doi: 10.1161/CIR.0000000000000950. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous